Introduction Intrinsic antitachycardia pacing (iATP) is a novel automated antitachycardia
pacing (ATP) that provides individual treatment to terminate ventricular tachycardia (VT) …

Intrinsic antitachycardia pacing (iATP) is a novel automated ventricular ATP algorithm that
designs ATP sequences based on the analysis of prior failed ATP. Real‐world data on the …

Antitachycardia pacing (ATP) offers a safe and painless termination of ventricular
tachycardia (VT) in patients with implantable cardioverter-defibrillators (ICDs). 1 However, it …

Intrinsic antitachycardia pacing (iATP) is a novel, automated antitachycardia pacing (ATP)
algorithm that provides individualized therapy to terminate ventricular tachycardia (VT). If the …

Background Intrinsic anti-tachycardia pacing (iATP™) is a novel, automated ATP algorithm
that provides individualized therapy to terminate ventricular tachycardia (VT). If the first ATP …

Conclusions First, ATP is a highly effective therapy, independent of patients characteristics.
Second, short VT cycle length and long ATP coupling intervals were identified as predictors …

Intrinsic anti-tachycardia pacing (iATP) is a novel automated ATP algorithm that employs
post-pacing interval (PPI) to design the next ATP sequence based on an analysis of the prior …

Background: Antitachycardia pacing (ATP) in implantable cardioverter-defibrillators (ICD)
decreases patient shock burden but has recognized limitations. A new automated ATP …

Background—Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden
cardiac death. The objective of this study was to evaluate whether testing of antitachycardia …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful
tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for those patients …